Boothbay Fund Management LLC Buys Shares of 1,237,057 CytomX Therapeutics, Inc. $CTMX

Boothbay Fund Management LLC purchased a new position in CytomX Therapeutics, Inc. (NASDAQ: CTMX) during the undefined quarter, according to its most recent disclosure with the SEC. The fund purchased 1,237,057 shares of the biotechnology company's stock, valued at approximately $3,946,000. Boothbay Fund Management LLC owned 0.73% of CytomX Therapeutics as of its